Nonavalent HPV vaccine vs quadrivalent HPV vaccine
High‐grade cervical, vulval, and vaginal disease · 9‐ to 26‐year‐old females and males
Nonavalent HPV vaccine showed no clear difference in high‐grade cervical, vulval, and vaginal disease at up to 4.5‐year compared with quadrivalent HPV vaccine (high certainty).
1 finding from 1 review
- Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes onlyOR 0.99 [0.85, 1.15]1 study · 14054 participantsHigh